SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001654954-24-004523
Filing Date
2024-04-11
Accepted
2024-04-11 16:56:47
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM POS AM tenx_posam.htm POS AM 380494
2 CONSENT tenx_ex231.htm EX-23.1 1901
3 tenx_posamimg1.jpg GRAPHIC 4330
4 tenx_posamimg2.jpg GRAPHIC 4332
  Complete submission text file 0001654954-24-004523.txt   395935
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-269363 | Film No.: 24839137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)